Atlas Trials

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)

Clinical trial NCT01231555 · TERMINATED

Trial details

NCT number
NCT01231555
Sponsor
ViiV Healthcare
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency Virus
Start date
2010-11-18
Primary completion
2011-07-04
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.